Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NEW YORK, Feb. 16, 2024 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH) (the "Company" or "Delcath"), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announces that the Company granted equity awards, previously approved by the Company's Compensation Committee, as a material inducement to the employment of three individuals whose employment commenced in January 2024.   The grant totaled the right to purchase an aggregate of 50,000 shares of the ...